Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
19 studies found for:    "Oncology, Medical"
Show Display Options
Rank Status Study
1 Completed Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters
Conditions: Oncology, Medical;   Hematologic Disease
Intervention: Drug: normal saline
2 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;;   Rhabdomyosarcoma;;   Ewing's Sarcoma;;   Ewing's Tumor;;   Sarcoma, Ewing's;;   Sarcomas, Epitheliod;;   Sarcoma, Soft Tissue;;   Sarcoma, Spindle Cell;;   Melanoma;;   Malignant Melanoma;;   Clinical Oncology;;   Oncology, Medical;;   Pediatrics, Osteosarcoma;;   Osteogenic Sarcoma;;   Osteosarcoma Tumor;;   Sarcoma, Osteogenic;;   Tumors;;   Cancer;;   Neoplasia;;   Neoplasm;;   Histiocytoma;;   Fibrosarcoma;;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
3 Not yet recruiting Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Condition: Medical Oncology
Interventions: Drug: BAY 1217389;   Drug: Paclitaxel
4 Recruiting Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Condition: Medical Oncology
Interventions: Drug: BAY1161909;   Drug: Paclitaxel
5 Active, not recruiting A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Conditions: Tumors;   Medical Oncology;   Neoplasms
Interventions: Drug: AGS-22M6E;   Drug: ASG-22CE
6 Not yet recruiting Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics
Conditions: Hematology;   Medical Oncology;   Nephrology;   Transplantation
Intervention: Procedure: blood drawing
7 Not yet recruiting Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Condition: Medical Oncology
Intervention: Drug: BAY1187982
8 Not yet recruiting The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance
Condition: Medical Oncology
Intervention: Device: pulsed electromagnetic field therapy
9 Recruiting COPANLISIB (BAY80-6946) Drug-drug Interaction Study in Advanced Solid Tumor Patients
Condition: Medical Oncology
Interventions: Drug: Copanlisib (BAY80-6946);   Drug: Itraconazole
10 Completed Transpulmonary Thermodilution Using an Implented Central Venous Access Port
Condition: Medical Oncology
Intervention: Other: Measurement of cardiac index
11 Recruiting The Use of Aromatherapy for Symptom Management
Condition: Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients
Intervention: Drug: Peppermint and Lavender Essential Oils
12 Completed Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy
Condition: Gastrointestinal Cancer
Interventions: Behavioral: Questionnaire;   Other: Interview
13 Terminated Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
Conditions: Anal Cancer;   Anxiety Disorder;   Breast Cancer;   Depression;   Esophageal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Kidney Cancer;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Other: questionnaire administration;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
14 Not yet recruiting Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer
Conditions: Resectable Pancreatic Cancer;   Ductal Adenocarcinoma of the Pancreas
Interventions: Drug: perioperative nab-paclitaxel/gemcitabine;   Drug: adjuvant nab-paclitaxel/gemcitabine
15 Completed Functional Evaluation of Two Types of Totally Implanted Venous Ports
Condition: Hematologic Disease
Intervention: Device: Vortex port and Celsite port
16 Active, not recruiting Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer
Conditions: Stomach Neoplasms;   Oesophageal Junction Cancer;   Lower Oesophagus Cancer
Interventions: Drug: Epirubicin;   Drug: Cisplatin;   Drug: Paclitaxel;   Procedure: gastric surgery
17 Not yet recruiting Community Central Line Infection Prevention Trial
Condition: Infection
Intervention: Device: 70% isopropyl alcohol embedded caps
18 Enrolling by invitation Evaluating the Impact of Patient-Centered Oncology Care
Condition: Neoplasms
Intervention: Other: Patient-Centered Oncology Care
19 Recruiting KOKON Consultation on Complementary Medicine in Oncology - a Pilot Study
Condition: Breast-cancer
Interventions: Behavioral: Consultation by a trained physician;   Behavioral: Consultation by an untrained physician

Indicates status has not been verified in more than two years